FMP
GlucoTrack, Inc.
GCTK
NASDAQ
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
0.352 USD
-0.0055 (-1.56%)
GCTK Financial Statements
Quarter
2024 Q3
2024 Q2
2024 Q1
2023 Q4
Total Revenue
0
0
0
42k
Cost of Revenue
0
8k
4k
21k
Gross Profit
0
-8k
-4k
21k
Operating Expenses
-3.25M
4.49M
2.95M
2.42M
Research and Development
2.06M
3.59M
2.15M
1.74M
Selling, General & Administrative Expenses
1.19M
902k
799k
675k
Selling & Marketing Expenses
125k
100k
70k
125k
General & Administrative Expenses
1.06M
802k
733k
550k
Other Expenses
-6.5M
0
0
0
Operating Income
3.25M
-4.49M
-2.95M
-2.42M
Total Other Income/Expenses Net
-8.34M
2k
24k
5k
Income Before Tax
-5.09M
-4.49M
-2.93M
-2.41M
Income Tax
0
0
-39.28k
12k
Net Income
-5.09M
-4.49M
-2.93M
-2.41M
Basic EPS
-0.93
-0.82
-0.59
-0.12
EPS Diluted
-0.93
-0.82
-0.59
-0.12
Basic Average Shares
5.48M
5.48M
4.99M
20.89M
Diluted Average Shares
5.48M
5.48M
4.99M
20.89M
EBITDA
-3.24M
-4.48M
-2.95M
-2.41M
All figures are in USD.
